Interim CFO Alton Neo joins Basel Medical Group (NASDAQ: BMGL)

Rhea-AI Filing Summary

Basel Medical Group Ltd has appointed Mr. Neo Chun How Alton as its new interim Chief Financial Officer, effective June 2, 2026. He replaces Ms. Jianing Lu, who resigned as CFO, with the Board expressing appreciation for her service.

Mr. Neo brings experience in corporate leadership, financial management, and education. He previously served as deputy CEO of InCorp Global’s Singapore operations, worked on tax policy at Singapore’s Ministry of Finance, helped develop the Singapore Chartered Accountant Qualification Programme, and teaches accounting-related courses at tertiary institutions. He holds an MBA from the University of Hull and multiple professional accounting and valuation memberships.

Insights

Corporate governance analyst

Basel Medical names an experienced interim CFO after its prior CFO resigns.

Basel Medical Group Ltd is transitioning its finance leadership, with Mr. Neo Chun How Alton appointed interim CFO following the resignation of Ms. Jianing Lu. The company maintains continuity by installing a replacement effective June 2, 2026.

Mr. Neo’s background spans deputy CEO responsibilities at InCorp Global’s Singapore operations, tax policy work at the Singapore Ministry of Finance, and contributions to the Singapore Chartered Accountant Qualification Programme. His mix of corporate, policy, and educational experience may support the company’s financial reporting and strategic planning.

The filing does not specify reasons for the prior CFO’s resignation or any related strategic changes, so the main takeaway is a leadership change in the finance function. Subsequent disclosures may provide more detail on how Mr. Neo’s appointment influences Basel Medical’s financial management and governance practices.

Key Terms

foreign private issuer, interim Chief Financial Officer, forensic accounting, Singapore Chartered Accountant Qualification Programme, +1 more

5 terms

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

interim Chief Financial Officer financial

"has appointed Mr. Neo Chun How Alton as its new interim Chief Financial Officer"

An interim chief financial officer is a temporary leader responsible for managing a company's financial activities, such as budgeting, financial planning, and reporting, during a transitional period. Think of it as filling in for a key manager until a permanent replacement is found. For investors, this role is important because it ensures financial stability and clear guidance during times of change or uncertainty.

forensic accounting financial

"he provides expertise in management reporting, corporate restructuring, business valuation, insolvency, and forensic accounting"

Forensic accounting is a specialized form of financial investigation where accountants act like detectives to examine records, trace money flows, and uncover fraud, embezzlement, or significant accounting errors. Investors care because these inquiries reveal hidden risks, misreported results, or weakened controls that can materially change a company’s value or future payouts, and their findings are often used in legal or regulatory actions to hold parties accountable.

Singapore Chartered Accountant Qualification Programme financial

"part of the pioneer team at the Singapore Accountancy Commission that developed the Singapore Chartered Accountant Qualification Programme"

Chartered Valuer financial

"Mr. Neo holds a Master of Business Administration, University of Hull and is also a Chartered Valuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number: 001-42527

Basel Medical Group Ltd

6 Napier Road,

Unit #02-10/11 Gleneagles Medical Centre

Singapore 258499

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Appointment of Interim Chief Financial Officer

The Board of Directors of Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) has appointed Mr. Neo Chun How Alton as its new interim Chief Financial Officer effective June 2, 2026. Mr. Neo was appointed as interim CFO to replace Ms. Jianing Lu, the CFO of the Company. Ms. Lu resigned from her position as CFO of the Company. The Board wishes to thank Ms. Lu for her service during her tenure.

Mr. Neo is a finance professional with extensive experience in corporate leadership, financial management, and education. Prior to joining Basel Medical, Alton served as the deputy CEO of InCorp Global’s Singapore operations, where he oversaw the entire Singapore’s operations – in particular, advisory and outsourcing services. In this role, he provides expertise in management reporting, corporate restructuring, business valuation, insolvency, and forensic accounting. Before his tenure at InCorp Global, Mr. Neo contributed to the Singapore Ministry of Finance as a tax policy associate, focusing on the development and review of tax incentives. He was also part of the pioneer team at the Singapore Accountancy Commission (now ACRA) that developed the Singapore Chartered Accountant Qualification Programme. In addition to his corporate roles, Mr. Neo is dedicated to education, having developed and taught courses in financial accounting and related subjects at leading tertiary institutions. Currently, he serves as a part-time tutor at the London School of Business & Finance in Singapore and Singapore University of Social Sciences.

Qualifications and Professional Memberships. Mr. Neo holds a Master of Business Administration, University of Hull and is also a Chartered Valuer, Institute of Valuers and Appraisers, CA Singapore, Institute of Singapore Chartered Accountants and CPA Australia.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Basel Medical Group Ltd
	By:	/s/ Darren Yen Feng Chhoa
	Name:	Dr. Darren Yen Feng Chhoa
	Title:	Chief Executive Officer
Date: June 5, 2026

FAQ

What leadership change did Basel Medical Group (BMGL) announce in this 6-K?

Basel Medical Group announced that Mr. Neo Chun How Alton was appointed interim Chief Financial Officer, effective June 2, 2026, replacing outgoing CFO Ms. Jianing Lu, who resigned. The Board thanked Ms. Lu for her service during her tenure.

Who is the new interim CFO of Basel Medical Group (BMGL)?

The new interim CFO is Mr. Neo Chun How Alton. He is a finance professional with experience in corporate leadership, financial management, advisory services, and education across roles in InCorp Global, Singapore’s Ministry of Finance, and leading tertiary institutions.

What experience does Basel Medical’s interim CFO bring to the role?

Mr. Neo previously served as deputy CEO of InCorp Global’s Singapore operations, oversaw advisory and outsourcing services, worked on tax policy at Singapore’s Ministry of Finance, helped develop the Singapore Chartered Accountant Qualification Programme, and teaches financial accounting and related subjects at tertiary institutions.

What qualifications does Basel Medical Group’s interim CFO hold?

Mr. Neo holds a Master of Business Administration from the University of Hull. He is also a Chartered Valuer and a member of the Institute of Valuers and Appraisers, CA Singapore, the Institute of Singapore Chartered Accountants, and CPA Australia, reflecting broad professional accreditation.

When did the new interim CFO of Basel Medical (BMGL) officially take office?

Mr. Neo’s appointment as interim Chief Financial Officer became effective on June 2, 2026. This effective date marks the formal transition of the company’s finance leadership following the resignation of the previous CFO, Ms. Jianing Lu.